Agonist and antagonist effects of apomorphine enantiomers on 5-HT3 receptors

Neuropharmacology

Volumn 37, Issue 2, 1998, Pages 259-264

  Van Hooft, J A ^a   Vijverberg, H P M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

5 HT3 receptor; Apomorphine; NIE 115 neuroblastoma cells; Stereoselectivity; Whole cell voltage clamp

Indexed keywords

APOMORPHINE; BEMESETRON; MDL 7222; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CULTURE; DESENSITIZATION; DOPAMINE BRAIN LEVEL; ENANTIOMER; MEMBRANE CURRENT; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; VOLTAGE CLAMP;

ANIMALS; APOMORPHINE; MICE; PATCH-CLAMP TECHNIQUES; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN AGENTS; STEREOISOMERISM; TUMOR CELLS, CULTURED;

EID: 0032004265     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00044-6     Document Type: Article

References (25)

1. Amano T., Richelson E., Nirenberg P.G. Neurotransmitter synthesis by neuroblastoma clones. Proc. Natl. Acad. Sci. U.S.A. 69:1972;258-263.
2. Campbell A., Baldessarini R.J., Teicher M.H., Neumeyer J.L. Behavioral effects of apomorphine isomers in the rat: Selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine. Psychopharmacology. 88:1986;158-164.
3. Campbell A.D., McBride W.J. Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens. Pharmacol. Biochem. Behav. 51:1995;835-842.
4. 3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br. J. Pharmacol. 92:1987;881-894.
5. 3 receptor antagonists attenuate dopamine-induced hyperactivity in the rat. Neuroreport. 1:1990;77-80.
6. 3 R-A subunit expressed in Xenopus laevis oocytes. Neuropharmacology. 33:1994;473-482.
7. Goldman M.E., Kebabian J.W. Aporphine enantiomers. Interactions with D-1 and D-2 dopamine receptors. Mol. Pharmacol. 25:1984;18-23.
8. 3 Receptors. 1992;59-88 Academic Press, London.
9. 3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol. Pharmacol. 33:1988;303-309.
10. Kula N.S., Baldessarini R.J., Bromley S., Neumeyer J.L. Effects of isomers of apomorphines on dopamine receptors in striatal and limbic tissue of rat brain. Life Sci. 37:1985;1051-1057.
11. 3 receptors in clonal cell lines studied by patch-clamp techniques. Br. J. Pharmacol. 97:1989;27-40.
12. Lee K.S., Akaike N., Brown A.M. Properties of internally perfused voltage clamped isolated nerve cell bodies. J. Gen. Physiol. 71:1978;489-507.
13. 3H]acetylcholine release in slices of cat caudate. Eur. J. Pharmacol. 88:1983;81-88.
14. Marquardt D.W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Indust. Appl. Math. 11:1963;431-441.
15. 3 receptor antagonists in rats. Psychopharmacology. 121:1995;488-493.
16. 3 receptor antagonist LY 277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells. Eur. J. Pharmacol. 209:1991;143-150.
17. 2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines. Brain Res. 492:1989;314-324.
18. 3 receptors in cultured mouse neuroblastoma cells. J. Physiol., London. 411:1989;257-269.
19. 3 receptor-mediated electrical response in cultured mouse neuroblastoma cells. Neuropharmacology. 27:1988;301-307.
20. 3 receptors. Eur. J. Pharmacol. 127:1986;271-274.
21. 3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol. 186:1990;327-330.
22. Saari W.S., King S.W., Lotti V.J. Synthesis and biological activity of (6aS)-10,11-dihydroxyaporphine, the optical antipode of apomorphine. J. Med. Chem. 16:1973;171-172.
23. 3 receptor ligand-gated ion channels. Recept. Channels. 3:1995;7-12.
24. 3 receptor by full and partial agonists. Br. J. Pharmacol. 117:1996;839-846.
25. 3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study. J. Pharmacol. Exp. Ther. 275:1995;358-367.